StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report released on Sunday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Brooklyn ImmunoTherapeutics stock opened at $1.87 on Friday. Brooklyn ImmunoTherapeutics has a 1-year low of $0.17 and a 1-year high of $10.10. The firm […]
StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note released on Saturday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Up 4.7 % NYSE BTX opened at $1.88 on Friday. The firm’s 50 day moving average is $1.45 and its 200-day moving average […]
StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report sent to investors on Saturday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance Brooklyn ImmunoTherapeutics stock opened at $1.88 on Friday. Brooklyn ImmunoTherapeutics has a 1 year low of $0.17 and a 1 year […]
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report report published on Friday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Up 9.4 % BTX stock opened at $1.87 on Friday. The firm has a market cap of $110.00 million, a price-to-earnings ratio of […]
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report released on Friday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Brooklyn ImmunoTherapeutics stock opened at $1.87 on Friday. Brooklyn ImmunoTherapeutics has a 1-year low of $0.17 and a 1-year high of $10.10. The firm […]